Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saypha Lips Lidocaine
- Development stage
- Unknown
- Lead developer
- Croma-Pharma
- Administration
- Intradermal
01
Overview
Saypha Lips Lidocaine is a cross-linked hyaluronic acid (HA) dermal filler developed by Croma-Pharma, specifically indicated for lip augmentation to correct moderate to severe lip volume deficiency, improve lip contour, and correct lip asymmetry. It is a sterile, biodegradable, viscoelastic, clear, absorbable, isotonic, and homogenized injectable gel implant, classified as a Class III medical device. The product contains 23 mg/mL of cross-linked hyaluronic acid in a physiologic buffer and incorporates 0.3% lidocaine hydrochloride as an ancillary anesthetic to reduce pain during the injection procedure. Designed with more elastic than viscous properties, it maintains its shape against the dynamic forces of lip movement, providing natural-looking volume and definition with effects lasting between 6 to 18 months.
- Brand names
- Croma Saypha LipsCroma Saypha Lips LidocaineSaypha Lips LidoSaypha Lips Lidocaine
- Other names
- cross-linked hyaluronic acid + lidocainehyaluronic acid + lidocainehyaluronic acid + lidocaine hydrochloride
02
Targets
HYAL (Hyaluronidase family (HYAL))SCN9A (Sodium channel protein type 9 subunit alpha)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Saypha Lips Lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Saypha Lips Lidocaine.